This segment focuses on the research, development, manufacturing, and commercialization of ophthalmic products, including intraocular lenses (IOLs), contact lens materials, and related accessories. Haohai Biological's R&D efforts concentrate on improving the biocompatibility and performance of IOLs and developing advanced materials for contact lenses. Technologies employed include polymer chemistry, precision manufacturing, and surface modification techniques. The segment addresses a wide range of ophthalmic conditions, including cataracts and refractive errors, improving patient vision and quality of life. Haohai Biological holds a strong market position in China and is expanding its global presence. Future opportunities include the development of innovative IOL designs and materials, as well as expansion into new geographic markets. Regulatory compliance and clinical trials are crucial for product approvals and market access. Partnerships with ophthalmologists and hospitals are key to market penetration and product adoption.

This segment encompasses the development, manufacturing, and sale of products for medical aesthetics and wound care. Haohai Biological's R&D activities focus on hyaluronic acid (HA)-based products, including dermal fillers and wound healing agents. The company utilizes advanced HA production technologies and formulation techniques to create products with enhanced efficacy and safety. Therapeutic applications include wrinkle reduction, facial contouring, and the treatment of chronic wounds. Patient impact is significant, as these products improve aesthetic outcomes and accelerate wound healing. Haohai Biological aims to strengthen its market position through product innovation, clinical validation, and strategic partnerships with dermatologists and plastic surgeons. Future growth opportunities include expanding the product portfolio, entering new geographic markets, and exploring new applications for HA-based technologies. Regulatory approvals and clinical trials are essential for market access and product credibility.

This segment focuses on the development, manufacturing, and distribution of orthopedic and hemostatic products. Haohai Biological's R&D efforts are directed towards creating innovative biomaterials for bone repair, joint reconstruction, and hemostasis. The company utilizes technologies such as collagen-based materials, absorbable polymers, and advanced manufacturing processes. Therapeutic areas include fracture repair, joint replacement, and the control of bleeding during surgical procedures. These products aim to improve patient outcomes by promoting bone healing, restoring joint function, and minimizing blood loss. Haohai Biological's market positioning is strengthened by its focus on innovative biomaterials and its commitment to clinical research. Future opportunities include the development of advanced bone grafts, bioabsorbable implants, and improved hemostatic agents. Regulatory compliance and clinical trials are critical for product approvals and market access. Partnerships with orthopedic surgeons and hospitals are essential for market penetration and product adoption.